Skip to main content
. 2021 Jan 8;11:542206. doi: 10.3389/fpsyt.2020.542206

Table 1.

Demographics of treatment-resistant patients and patients with good outcomes at admission.

Variable N Treatment resistant % or median (IQR) Good outcome % or median (IQR) Test of significance
Diagnosis 75 x2(1) = 16.99, p < 0.001
 AN-R 37.8% 84.2%
 AN-BP 62.2% 15.8%
Gender 75 x2(1) = 2.00, p = 0.157
 Female 100% 94.7%
 Male 0% 5.3%
Occupation 66 x2(2) = 6.15, p = 0.046
 Employed 37.9% 40.5%
 Student 27.6% 48.6%
 Unemployed 34.5% 10.8%
Living Situation 65 x2(3) = 0.688, p = 0.876
 Independent 13.8% 13.9%
 Parents 55.2% 63.9%
 Partner/children 27.6% 19.4%
 Roommates 3.4% 2.8%
Age 74 24.00 (21.50, 30.00) 22.00 (20.00, 27.00) U = 556.50, p = 0.167
Duration of illness in years 69 6.84 (2.62, 12.32) 2.87 (1.46, 9.43) U = 440.50, p = 0.068
BMI in kg/m2 75 14.36 (13.56, 15.60) 15.59 (13.85, 16.38) U = 558.00, p = 0.124
EDEQ total score 55 5.29 (4.76, 5.59) 4.57 (3.35, 5.17) U = 179.00, p = 0.003
BDI total score 57 46.00 (34.00, 53.00) 33.00 (21.00, 40.50) U = 159.00, p < 0.001
Weekly # days of excessive exercise in 3 months before tx 69 2.80 (0, 6.63) 4.00 (0, 7.00) U = 544.50, p = 0.553
Weekly # of binge episodes in 3 months before tx (BP subtype) 23 0.17 (0, 6.67) 0.00 (0, 0.33) U = 40.0, p = 0.406
Weekly # of purge episodes in 3 months before tx (BP subtype) 24 7.33 (2.83, 28.08) 5.17 (0, 11.33) U = 38.50, p = 0.300